Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Net Margin (2017 - 2025)

Creative Medical Technology Holdings has reported Net Margin over the past 9 years, most recently at 74334.93% for Q4 2025.

  • Quarterly Net Margin rose 2489220.0% to 74334.93% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 105623.03% through Dec 2025, down 4547557.0% year-over-year, with the annual reading at 105623.03% for FY2025, 4547557.0% down from the prior year.
  • Net Margin was 74334.93% for Q4 2025 at Creative Medical Technology Holdings, down from 54603.23% in the prior quarter.
  • Over five years, Net Margin peaked at 1786.07% in Q3 2022 and troughed at 99227.13% in Q4 2024.
  • The 5-year median for Net Margin is 26910.77% (2021), against an average of 35372.47%.
  • Biggest five-year swings in Net Margin: soared 21536391bps in 2021 and later plummeted -4327467bps in 2024.
  • Tracing CELZ's Net Margin over 5 years: stood at 5719.92% in 2021, then tumbled by -484bps to 33417.7% in 2022, then plummeted by -67bps to 55952.47% in 2023, then crashed by -77bps to 99227.13% in 2024, then grew by 25bps to 74334.93% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 74334.93%, 54603.23%, and 99227.13% for Q4 2025, Q1 2025, and Q4 2024 respectively.